This report considers the markets for therapeutic cardiovascular devices, such as prosthetic valves, pacemakers, stents, support devices, ICDs, VADs, and TAHs, in the United States as broken down into four major segments: cardiomyopathy/congestive heart failure arrhythmias arteriosclerosis (coronary artery disease), and valvular heart disease While there are other cardiovascular conditions that remain significant in the […]
September 1, 2005
Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area, but it is by no means the easiest to compete in. There are millions of surgical procedures performed annually worldwide; in the United States alone, there are over 100,000 surgeries performed daily. Enjoying market success depends […]
September 1, 2005
Management of both acute and chronic neurologic diseases can be challenging for both the patient and the health care provider. Many neurologic disorders involve progressive deterioration in physical and mental capabilities, which can be devastating to the patient and the patient’s family. In many respects, neurotherapeutics represent the largest as-yet untapped market in medicine. This […]
September 1, 2005
One of the keys to understanding many complex biological interactions, is the role played by specific carbohydrates. This is glycobiology. While many glycobiology-related products commercialized to date are detection and analysis kits for analyzing glycoproteins and the extent of glycosylation, a newer body of research is harnessing glycobiology to develop glycol-based drugs, or glycotherapeutics. The […]
September 1, 2005
Approximately 27 million burn cases requiring professional treatment occur worldwide each year, and of these 7 million will require hospitalization and more than a million will die as a direct result of their burns. Burn injuries are a particularly difficult and painful area of medicine requiring multi-pronged approach to address infection, pain, and a host […]
August 1, 2005
This market briefing concentrates on the U.S. market for medical nutritional support—in particular, the enteral and parenteral foods. The continuing development of equipment, medical foods, and feeding procedures that secure the nutrition of critically ill patents has greatly improved recovery and survival in select populations. Advances in the effectiveness and safety of nutritional procedures and […]
August 1, 2005
Neurological disease that impacts the sensory pathway can produce severe chronic pain, also known as neuropathic pain. This usually is unrelated to any peripheral tissue injury. This occurs with disorders of the central nervous system (CNS), such as stroke and multiple sclerosis, or with conditions associated with peripheral nerve damage, such as mechanical injury, diabetic […]
August 1, 2005
The aging of the population and continued advances in biotechnology drive the skin ulcer portion of the wound care industry, estimated at $3.3 billion globally. A lack of effective treatment options has heretofore added to the increased costs of skin ulcer treatment and has contributed to the growing frustration in the industry. New product manufacturers […]
July 1, 2005
This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key […]
July 1, 2005
Analytical microchips continue to be among the fastest growing technology segments of the life sciences. The range of applications to which these miniature laboratories may be directed is very broad, covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, […]
June 1, 2005